These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35246229)

  • 21. Immune Gene Expression Covaries with Gut Microbiome Composition in Stickleback.
    Fuess LE; den Haan S; Ling F; Weber JN; Steinel NC; Bolnick DI
    mBio; 2021 May; 12(3):. PubMed ID: 33947750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysis.
    Merelli I; Viti F; Milanesi L
    BMC Bioinformatics; 2012; 13 Suppl 14(Suppl 14):S5. PubMed ID: 23095257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota as Therapeutic Targets.
    Xavier RJ
    Dig Dis; 2016; 34(5):558-65. PubMed ID: 27331403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiome, gut function, and probiotics: Implications for health.
    Hajela N; Ramakrishna BS; Nair GB; Abraham P; Gopalan S; Ganguly NK
    Indian J Gastroenterol; 2015 Mar; 34(2):93-107. PubMed ID: 25917520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbiota Host-Gene Interaction.
    Cuomo P; Capparelli R; Alifano M; Iannelli A; Iannelli D
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic effects on the commensal microbiota in inflammatory bowel disease patients.
    Aschard H; Laville V; Tchetgen ET; Knights D; Imhann F; Seksik P; Zaitlen N; Silverberg MS; Cosnes J; Weersma RK; Xavier R; Beaugerie L; Skurnik D; Sokol H
    PLoS Genet; 2019 Mar; 15(3):e1008018. PubMed ID: 30849075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease.
    Ghosh TS; Arnoux J; O'Toole PW
    Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 32985923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking Microbiota to Human Diseases: A Systems Biology Perspective.
    Wu H; Tremaroli V; Bäckhed F
    Trends Endocrinol Metab; 2015 Dec; 26(12):758-770. PubMed ID: 26555600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microbiome in inflammatory bowel disease: current status and the future ahead.
    Kostic AD; Xavier RJ; Gevers D
    Gastroenterology; 2014 May; 146(6):1489-99. PubMed ID: 24560869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent selection-induced obesity alters the composition and functional pathways of chicken gut microbiota.
    Ding J; Zhao L; Wang L; Zhao W; Zhai Z; Leng L; Wang Y; He C; Zhang Y; Zhang H; Li H; Meng H
    Genet Sel Evol; 2016 Nov; 48(1):93. PubMed ID: 27894254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in Genome-Scale Metabolic Modeling toward Microbial Community Analysis of the Human Microbiome.
    Esvap E; Ulgen KO
    ACS Synth Biol; 2021 Sep; 10(9):2121-2137. PubMed ID: 34402617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating host-microbiome interactions by droplet based microfluidics.
    Tauzin AS; Pereira MR; Van Vliet LD; Colin PY; Laville E; Esque J; Laguerre S; Henrissat B; Terrapon N; Lombard V; Leclerc M; Doré J; Hollfelder F; Potocki-Veronese G
    Microbiome; 2020 Oct; 8(1):141. PubMed ID: 33004077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.